These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
275 related articles for article (PubMed ID: 8845691)
1. Clozapine as a treatment for psychosis in Parkinson's disease: a review. Musser WS; Akil M J Neuropsychiatry Clin Neurosci; 1996; 8(1):1-9. PubMed ID: 8845691 [TBL] [Abstract][Full Text] [Related]
2. Treatment of behavioural symptoms and dementia in Parkinson's disease. Hanagasi HA; Emre M Fundam Clin Pharmacol; 2005 Apr; 19(2):133-46. PubMed ID: 15810893 [TBL] [Abstract][Full Text] [Related]
3. Novel pharmaceuticals in the treatment of psychosis in Parkinson's disease. Broadstock M; Ballard C; Corbett A Expert Rev Clin Pharmacol; 2014 Nov; 7(6):779-86. PubMed ID: 25301532 [TBL] [Abstract][Full Text] [Related]
4. Current Understanding of Psychosis in Parkinson's Disease. Ojo OO; Fernandez HH Curr Psychiatry Rep; 2016 Oct; 18(10):97. PubMed ID: 27629356 [TBL] [Abstract][Full Text] [Related]
5. [Drug treatment of dementia with Lewy bodies and Parkinson's disease dementia--common features and differences]. Drach LM Med Monatsschr Pharm; 2011 Feb; 34(2):47-52; quiz 53-4. PubMed ID: 21428015 [TBL] [Abstract][Full Text] [Related]
6. Clozapine in Parkinson's disease psychosis: 5-year follow-up review. Klein C; Gordon J; Pollak L; Rabey JM Clin Neuropharmacol; 2003; 26(1):8-11. PubMed ID: 12567158 [TBL] [Abstract][Full Text] [Related]
7. Low dose of clozapine in the treatment of dopaminergic psychosis in Parkinson's disease. Ruggieri S; De Pandis MF; Bonamartini A; Vacca L; Stocchi F Clin Neuropharmacol; 1997 Jun; 20(3):204-9. PubMed ID: 9197942 [TBL] [Abstract][Full Text] [Related]
9. Clozapine for the treatment of psychosis in Parkinson's disease: chart review of 49 patients. Wagner ML; Defilippi JL; Menza MA; Sage JI J Neuropsychiatry Clin Neurosci; 1996; 8(3):276-80. PubMed ID: 8854298 [TBL] [Abstract][Full Text] [Related]
10. Management of psychosis in Parkinson's disease. D'Souza C; Gupta A; Alldrick MD; Sastry BS Int J Clin Pract; 2003 May; 57(4):295-300. PubMed ID: 12800461 [TBL] [Abstract][Full Text] [Related]
11. [Clozapine and olanzapine in the treatment of the psychotic disorders in Parkinson's disease]. Chacón J Rev Neurol; 2004 Oct 1-15; 39(7):655-60. PubMed ID: 15490354 [TBL] [Abstract][Full Text] [Related]
13. Clozapine treatment of psychosis in Parkinson's disease: a report of five consecutive cases. Wolk SI; Douglas CJ J Clin Psychiatry; 1992 Oct; 53(10):373-6. PubMed ID: 1358876 [TBL] [Abstract][Full Text] [Related]
14. Management of hallucinations and psychosis in Parkinson's disease. Eng ML; Welty TE Am J Geriatr Pharmacother; 2010 Aug; 8(4):316-30. PubMed ID: 20869621 [TBL] [Abstract][Full Text] [Related]
15. Pathophysiology and treatment of psychosis in Parkinson's disease: a review. Zahodne LB; Fernandez HH Drugs Aging; 2008; 25(8):665-82. PubMed ID: 18665659 [TBL] [Abstract][Full Text] [Related]
16. [Clozapine for the treatment of psychosis in 3 elderly patients with Parkinson's disease]. Diraoui S; van Melick EJ; Jansen PA Ned Tijdschr Geneeskd; 2004 Nov; 148(48):2365-8. PubMed ID: 15615268 [TBL] [Abstract][Full Text] [Related]
17. Rater-blinded, prospective comparison: quetiapine versus clozapine for Parkinson's disease psychosis. Merims D; Balas M; Peretz C; Shabtai H; Giladi N Clin Neuropharmacol; 2006; 29(6):331-7. PubMed ID: 17095896 [TBL] [Abstract][Full Text] [Related]
18. [Psychosis in Parkinson's disease]. Rongve A; Auning E; Ehrt U; Arsland D Tidsskr Nor Laegeforen; 2012 Jan; 132(2):155-8. PubMed ID: 22278271 [TBL] [Abstract][Full Text] [Related]
19. Atypical antipsychotic drugs in the treatment of Parkinson's disease. Friedman JH J Pharm Pract; 2011 Dec; 24(6):534-40. PubMed ID: 22095576 [TBL] [Abstract][Full Text] [Related]